BIO International Convention 2026

Richmond Pharmacology is excited to join the BIO International Convention 2026 in San Diego, USA, on 22–25 June 2026.

Uniting global leaders in biotechnology, this convention serves as a hub for ground breaking research, strategic partnerships, and transformative solutions shaping the future of life sciences.

Representing Richmond Pharmacology at the BIO International Convention 2026:

• Dr Jörg Taubel, Chief Executive Officer

• Stephen Wilkinson, Business Development Manager
• Dr Lisa Campbell, Director of Regulatory Strategy

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in biotechnology and clinical trial design

• Regulatory pathways for emerging therapies

• Patient-centric approaches and recruitment strategies

• Collaboration between academia, industry, and regulators

• Data-driven solutions for accelerating development

‍

Connect With Us

If you are attending BIO International Convention 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍